Editor, Jade Parker recently spoke with David Adams, Senior Group Leader at the Wellcome Trust Sanger Institute (Cambridge, UK).
David utilizes DNA sequencing of patients and genetic screens in human cells and mice to identify cancer genes and genetic interactions. In this interview you can find out about:
- Advancements that have been made in DNA sequencing in regards to colorectal and melanoma cancer
- How David became involved in the field of cancer genetics
- How the factors such as the immune system and stroma effect tumor development
- How his team are looking to build interactive to see how genes work to drive tumor development
To see all the videos in this series of interviews with cancer genomics opinion leaders, subscribe to our Youtube channel.